NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,244 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
40,244 Papers indexed
1,440 Papers AI scored
40,244 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-08 10:15 AM
1 Exploring the Limits of Robotic Surgery for Wilms Tumor: A Descriptive Analysis. European urology oncology — Nov 08, 2026 2 Effectiveness of Upfront Radiotherapy in Central Nervous System Germ Cell Tumors. Practical radiation oncology — Nov 08, 2026 3 Integrative network toxicology and clinical validation identify CD4, PTGS2, and KDR as candidate targets of nicotine in infantile hemangioma. Gene — Nov 08, 2026 4 Characterization of N-glycosylation remodeling in cerebrospinal fluid extracellular vesicles in children with purulent meningitis and viral meningitis: an exploratory glycomics study based on MALDI-TOF/TOF-MS. Glycoconjugate journal — Nov 08, 2026 5 Willingness to participate and model preference for integrated medical and elderly care among older patients with cancer in China: a cross sectional study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer — Nov 08, 2026 6 Public Participation in U.S. Food and Drug Administration (FDA) Advisory Committees: A Qualitative Analysis. Therapeutic innovation & regulatory science — Nov 08, 2026 7 Dose-related depressive symptoms and suicidal ideation during cabergoline therapy in an adolescent with macroprolactinoma. JCEM case reports — Nov 08, 2026 8 Pediatric gigantism due to ectopic growth hormone releasing hormone secretion from a metastatic bronchial neuroendocrine tumor. JCEM case reports — Nov 08, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40244 results
D
The Impact of Infectious Mononucleosis History on the Risk of Developing Lymphoma and Nasopharyngeal Carcinoma: A Retrospective Large-Scale Cohort Study Using National Health Insurance Data in South Korea.
PMID 38665055 Published: 2024-04-23 Ingested: 2026-08-02 12:02 AM Cancer research and treatment
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 85.0.

D
Arachnoid cyst in the pediatric patient: What the radiologist needs to know.
PMID 38649153 Published: 2024-04-22 Ingested: 2026-08-02 12:05 AM The neuroradiology journal
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 85.0.

D
Immunological and hematological findings as major features in a patient with a new germline pathogenic CBL variant.
PMID 38613168 Published: 2024-04-12 Ingested: 2026-08-02 12:02 AM American journal of medical genetics. Part A
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 85.0.

D
Social Anxiety Symptoms in Adolescents and Young Adults Recently Diagnosed with Cancer.
PMID 38597951 Published: 2024-04-09 Ingested: 2026-08-02 12:02 AM Journal of adolescent and young adult oncology
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 85.0.

D
Is mediastinal fine needle aspiration cytology required or redundant? A single institution-based correlation study with core needle biopsy.
PMID 38574567 Published: 2024-03-29 Ingested: 2026-08-02 12:02 AM Annals of diagnostic pathology
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 85.0.

D
A comprehensive histomolecular characterization of meningioangiomatosis: Further evidence for a precursor neoplastic lesion.
PMID 38565263 Published: 2024-04-02 Ingested: 2026-08-02 12:03 AM Brain pathology (Zurich, Switzerland)
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 85.0.

D
Links of Previous Incarceration With Geriatric Syndromes and Chronic Health Conditions Among Older Adults in the United States.
PMID 38518090 Published: 2024-08-01 Ingested: 2026-08-02 12:02 AM The journals of gerontology. Series A, Biological sciences and medical sciences
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 85.0.

D
Financial Aid in Children, Adolescents and Young Adult's Cancer Care: A Scoping Review.
PMID 38451723 Published: 2024-03-06 Ingested: 2026-08-02 12:02 AM Journal of adolescent and young adult oncology
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 85.0.

D
Committed Lone Fighters And Group Experiences: An International Survey On Pediatric Hematology And Oncology Training In German-Speaking Countries.
PMID 38428466 Published: 2024-03-01 Ingested: 2026-08-02 12:03 AM Klinische Padiatrie
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 85.0.

D
UBTF tandem duplications in pediatric myelodysplastic syndrome and acute myeloid leukemia: implications for clinical screening and diagnosis.
PMID 38426285 Published: 2024-08-01 Ingested: 2026-08-02 12:02 AM Haematologica
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 85.0.

D
'I was able to make a better decision about my health.' Wāhine experiences of colposcopy at a marae-based health clinic: A qualitative study.
PMID 38425188 Published: 2024-02-29 Ingested: 2026-08-02 12:02 AM The Australian & New Zealand journal of obstetrics & gynaecology
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 85.0.

Previous
Page 2733 of 3354
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic